Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies

被引:31
作者
Aroner, Sarah A. [1 ]
Collins, Laura C. [2 ,3 ]
Connolly, James L. [2 ,3 ]
Colditz, Graham A. [4 ]
Schnitt, Stuart J. [2 ,3 ]
Rosner, Bernard A. [3 ,5 ,6 ]
Hankinson, Susan E. [3 ,5 ,7 ]
Tamimi, Rulla M. [1 ,3 ,5 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[5] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[7] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA
基金
美国国家卫生研究院;
关键词
Benign breast disease; Breast cancer; Breast pathology; Nested case-control; Radial scars; ATYPICAL HYPERPLASIA; MALIGNANT BREAST; NUCLEAR-ORGANIZATION; TUBULAR CARCINOMA; TISSUE STRUCTURE; GENE-EXPRESSION; DISEASE; LESIONS; BIOPSIES; WOMEN;
D O I
10.1007/s10549-013-2535-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radial scars (RS) are benign proliferative lesions associated with an increased risk of subsequent breast cancer. However, it remains unclear whether RS are an independent risk factor for breast cancer or whether their association with breast cancer is due to their common occurrence with other proliferative lesions known to increase breast cancer risk. We performed an updated analysis of the association between RS and subsequent breast cancer risk in a nested case-control study among 460 cases and 1,792 controls with benign breast disease (BBD) in the Nurses' Health Studies. Logistic regression was used to estimate associations between RS in BBD biopsy specimens and breast cancer risk, adjusted for matching factors and breast cancer risk factors, including histologic category of concurrent BBD. In multivariable models prior to adjustment for histologic category of BBD, RS were associated with a twofold increased risk of breast cancer (odds ratio (OR) = 2.0; 95 % confidence interval (95 % CI) 1.4, 2.8). This association was attenuated but still significant after adjustment for BBD histologic category (OR = 1.6; 95 % CI 1.1, 2.3). In models adjusted for BBD histologic category and other covariates, risk appeared greater among women with multiple RS (1 RS, OR = 1.5; 95 % CI 0.9, 2.3; a parts per thousand yen2 RS, OR = 2.7; 95 % CI 1.5, 5.0; p-heterogeneity = 0.12). There were also suggestions of a greater risk associated with RS among women age a parts per thousand yen50 years at biopsy (p-heterogeneity = 0.07) and for estrogen receptor-negative/progesterone receptor-negative tumors compared with other hormone receptor subtypes (p-heterogeneity = 0.19). RS appear to be an independent histologic risk factor for breast cancer. Larger studies are needed to further evaluate whether risk is increased when multiple RS are present and whether associations vary by age at biopsy or by hormone receptor status of the breast tumor.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [41] Chronotype and Breast Cancer Risk in a Cohort of US Nurses
    Ramin, Cody
    Devore, Elizabeth E.
    Pierre-Paul, Jeffrey
    Duffy, Jeanne F.
    Hankinson, Susan E.
    Schernhammer, Eva S.
    CHRONOBIOLOGY INTERNATIONAL, 2013, 30 (09) : 1181 - 1186
  • [42] Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
    Langballe, Rikke
    Mellemkjaer, Lene
    Malone, Kathleen E.
    Lynch, Charles F.
    John, Esther M.
    Knight, Julia A.
    Bernstein, Leslie
    Brooks, Jennifer
    Andersson, Michael
    Reiner, Anne S.
    Liang, Xiaolin
    Woods, Meghan
    Concannon, Patrick J.
    Bernstein, Jonine L.
    BREAST CANCER RESEARCH, 2016, 18
  • [43] Periodontal disease, tooth loss and colorectal cancer risk: Results from the Nurses' Health Study
    Momen-Heravi, Fatemeh
    Babic, Ana
    Tworoger, Shelley S.
    Zhang, Libin
    Wu, Kana
    Smith-Warner, Stephanie A.
    Ogino, Shuji
    Chan, Andrew T.
    Meyerhardt, Jeffrey
    Giovannucci, Edward
    Fuchs, Charles
    Cho, Eunyoung
    Michaud, Dominique S.
    Stampfer, Meir J.
    Yu, Yau-Hua
    Kim, David
    Zhang, Xuehong
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (03) : 646 - 652
  • [44] Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II
    Hirko, Kelly A.
    Fortner, Renee T.
    Hankinson, Susan E.
    Wu, Tianying
    Eliassen, A. Heather
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 149 - 155
  • [45] Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses' Health Study
    Fortner, Renee T.
    Tworoger, Shelley S.
    Wu, Tianying
    Eliassen, A. Heather
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 141 (02) : 307 - 316
  • [46] Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
    Collins, Laura C.
    Cole, Kimberly S.
    Marotti, Jonathan D.
    Hu, Rong
    Schnitt, Stuart J.
    Tamimi, Rulla M.
    MODERN PATHOLOGY, 2011, 24 (07) : 924 - 931
  • [47] A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer
    Geoffrey C. Kabat
    Joan G. Jones
    Neal Olson
    Abdissa Negassa
    Catherine Duggan
    Mindy Ginsberg
    Rita A. Kandel
    Andrew G. Glass
    Thomas E. Rohan
    Cancer Causes & Control, 2010, 21 : 821 - 828
  • [48] Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study
    Posso, Margarita
    Corominas, Josep M.
    Serrano, Laia
    Roman, Marta
    Tora-Rocamora, Isabel
    Domingo, Laia
    Romero, Anabel
    Jesus Quintana, Maria
    Vernet-Tomas, Maria
    Bare, Marisa
    Vidal, Carmen
    Sanchez, Mar
    Saladie, Francina
    Natal, Carmen
    Ferrer, Joana
    Servitja, Sonia
    Sala, Maria
    Castells, Xavier
    CANCER MEDICINE, 2017, 6 (06): : 1482 - 1489
  • [49] Surgical excision of radial scars diagnosed by core biopsy may help predict future risk of breast cancer
    Miller, Cynthia L.
    West, Jane A.
    Bettini, Anna C.
    Koerner, Frederick C.
    Gudewicz, Thomas M.
    Freer, Phoebe E.
    Coopey, Suzanne B.
    Gadd, Michele A.
    Hughes, Kevin S.
    Smith, Barbara L.
    Rafferty, Elizabeth
    Specht, Michelle C.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (02) : 331 - 338
  • [50] Intrauterine device use and risk of ovarian cancer: Results from the New England Case-Control study and Nurses' Health Studies
    Yang, Jiaxi
    Sasamoto, Naoko
    Babic, Ana
    Vitonis, Allison F.
    Townsend, Mary K.
    Titus, Linda
    Cramer, Daniel W.
    Tworoger, Shelley S.
    Terry, Kathryn L.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (01) : 75 - 83